Filing Details
- Accession Number:
- 0001127602-17-009216
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-01 15:44:56
- Reporting Period:
- 2017-02-28
- Filing Date:
- 2017-03-01
- Accepted Time:
- 2017-03-01 15:44:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-02-28 | 100 | $88.37 | 382,900 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-28 | 100 | $88.38 | 382,800 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-28 | 200 | $88.38 | 382,600 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-28 | 100 | $88.40 | 382,500 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-28 | 200 | $88.44 | 382,300 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-28 | 200 | $88.45 | 382,100 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-28 | 100 | $88.62 | 382,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-28 | 200 | $88.64 | 381,800 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-28 | 50 | $88.79 | 381,750 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-28 | 20 | $88.89 | 381,730 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-28 | 2,396 | $89.54 | 379,334 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2017-02-28 | 13,656 | $0.00 | 365,678 | No | 5 | G | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 5 | G | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 340 | Indirect | By Trust |
| Common Stock | 10,000 | Indirect | Held By Spouse |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
Billionaire Hedge Funds
